User login
Enter your username and password here in order to log in on the website:
“These patients often have adequate function of their ventricle but extremely poor circulation due to this unphysiological flow pattern after Fontan surgery. In this situation, artificial sub-pulmonary support is the only way to normalize hemodynamics, allow for organ recovery during mechanical support therapy and consequently has the potential to lower mortality and morbidity on the waiting list. Moreover, we are confident that we can reduce the risk of the heart transplantation in failing Fontan hemodynamics.”
Prof. Dr. Nikolaus Haas, LMU University Hospital Munich, Germany,
“This specially designed cannula could lead to a significant shortening of operation time and due to flow optimization to a decreased risk for thromboembolic events.”
Dr. Eugen Sandica, Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany
“The venous cannula offers a standardized implantation of the EXCOR® device for support of the subpulmonary circulation in Fontan patients.”
Prof. Dr. Daniel Zimpfer, Medical University of Vienna, Austria
“RVAD or BVAD support can normalize hemodynamics, allow for organ recovery during mechanical support and consequently has the potential to lower mortality and morbidity on the waiting list.”
Prof. Dr. med. Stanislav Ovroutski, German Heart Institute Berlin
Indicated for RVAD and BVAD patients with a BSA ≥ 1.2 m².
The access to some or all shown products may be restricted due to country-specific regulatory approvals. IKUS and EXCOR® Active are/is intended for professional healthcare facility environments only.
The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Blood pumps with bileaflet valves, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft, Caddy quattro kit as well as Excor mobile is not FDA approved. EXCOR® Active is an investigational device approved for pediatric use in a clinical study under IDE# G200252 approved by the FDA.